Directors’ Outlook For Economy Dims To Pre-Vaccine Levels On Inflation Fears
Our gauge of U.S. public company board member confidence is now just 3 percent above where it was last fall, before Covid-19 vaccines were released.
Our gauge of U.S. public company board member confidence is now just 3 percent above where it was last fall, before Covid-19 vaccines were released.
Among those against the idea, the most common reason is loss of competitiveness for U.S. companies.